Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Feb 17:24:202-206.
doi: 10.1016/j.xjtc.2024.02.009. eCollection 2024 Apr.

How I do it: Bronchial sleeve resection and pulmonary angioplasty techniques after induction chemo-immunotherapy

Alper Toker  1 , Jahnavi Kakuturu  1
Affiliations
Editorial

How I do it: Bronchial sleeve resection and pulmonary angioplasty techniques after induction chemo-immunotherapy

Alper Toker et al. JTCVS Tech. .
No abstract available

Keywords: bronchial sleeve; pulmonary artery reconstruction.

PubMed Disclaimer

Conflict of interest statement

The authors reported no conflicts of interest. The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest.

Figures

None
The technique to be performed on the PA could be decided after division of bronchus.
Figure 1
Figure 1
Left: assessment of the PA after division of bronchus. Right: Picture sleeve resection was performed to assess the right main PA. Both patients after neoadjuvant chemo-immunotherapy.
See this image and copyright information in PMC

References

    1. Bott M., Yang S., Park B., et al. Initial results of pulmonary resection following neoadjuvant nivolumab in patients with resectable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2019;158:269–276. doi: 10.1016/j.jtcvs.2018.11.124. - DOI - PMC - PubMed
    1. Jiang L., Huang J., Jiang S., et al. The surgical perspective in neoadjuvant immunotherapy for resectable non-small cell lung cancer. Cancer Immunol Immunother. 2021;70:2313–2321. doi: 10.1007/s00262-021-02847-1. - DOI - PMC - PubMed
    1. Gao S.J., Corso C.D., Wang E.H., et al. Timing of surgery after neoadjuvant chemoradiation in locally advanced non-small cell lung cancer. J Thorac Oncol. 2017;12:314–322. doi: 10.1016/j.jtho.2016.09.122. - DOI - PubMed
    1. Mittenford H., Burgers F., Haanen J., Cascone T. ASCO Educational Book; 2022. Neoadjuvant Immunotherapy: Leveraging Immune System to Treat Early Stage Disease; pp. 189–203. - PubMed
    1. Huynh C., Walsh L., Spicer J. Surgery after neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer. Transl Lung Cancer Res. 2021;10:563–580. doi: 10.21037/tlcr-20-509. - DOI - PMC - PubMed

Publication types

LinkOut - more resources